APA
Amatu A., Barault L., Moutinho C., Cassingena A., Bencardino K., Ghezzi S., Palmeri L., Bonazzina E., Tosi F., Ricotta R., Cipani T., Crivori P., Gatto R., Chirico G., Marrapese G., Truini M., Bardelli A., Esteller M., Di Nicolantonio F., Sartore-Bianchi A. & Siena S. (20171226). Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Amatu A, Barault L, Moutinho C, Cassingena A, Bencardino K, Ghezzi S, Palmeri L, Bonazzina E, Tosi F, Ricotta R, Cipani T, Crivori P, Gatto R, Chirico G, Marrapese G, Truini M, Bardelli A, Esteller M, Di Nicolantonio F, Sartore-Bianchi A and Siena S. 20171226. Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Amatu A., Barault L., Moutinho C., Cassingena A., Bencardino K., Ghezzi S., Palmeri L., Bonazzina E., Tosi F., Ricotta R., Cipani T., Crivori P., Gatto R., Chirico G., Marrapese G., Truini M., Bardelli A., Esteller M., Di Nicolantonio F., Sartore-Bianchi A. and Siena S. (20171226). Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Amatu A, Barault L, Moutinho C, Cassingena A, Bencardino K, Ghezzi S, Palmeri L, Bonazzina E, Tosi F, Ricotta R, Cipani T, Crivori P, Gatto R, Chirico G, Marrapese G, Truini M, Bardelli A, Esteller M, Di Nicolantonio F, Sartore-Bianchi A and Siena S. Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20171226.